Results 101 to 110 of about 26,786 (248)

Coming down the “chimney”: Percutaneous coronary intervention on a post‐transcatheter aortic valve replacement with valve‐in‐valve patient

open access: yes, 2022
Accessing the coronary arteries post‐transcatheter aortic valve replacement is a growing challenge. This is a case of a patient requiring percutaneous coronary intervention on a left circumflex artery after a TAVR valve‐in‐valve and a left main “chimney”
Adam Taleb
core   +1 more source

Neosinus and Valve Thrombosis After Transcatheter Aortic Valve Replacement

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Transcatheter aortic valve replacement is regarded as an effective intervention for patients with aortic stenosis and has now been extended to low‐risk populations.
Nan Chen, Yu Mao, Hui‐Ping Zhang
doaj   +1 more source

Recent advances in aortic valve replacement for aortic stenosis [version 1; referees: 2 approved]

open access: yesF1000Research, 2016
Aortic valve replacement is no longer an operation that is approached solely through a median sternotomy. Recent advances in the fields of transcatheter valves have expanded the proportion of patients eligible for intervention.
Ahmed Al-Adhami, Nawwar Al-Attar
doaj   +1 more source

Clinical Significance of Anti‐Atezolizumab Antibodies in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

open access: yesHepatology Research, EarlyView.
ABSTRACT Aim Systemic therapy is required for unresectable hepatocellular carcinoma (HCC). Atezolizumab plus bevacizumab (ATZ/BEV) is the recommended first‐line treatment for HCC; however, the development of anti‐drug antibodies (ADAs) against ATZ may impair its therapeutic efficacy. Although ADAs have been reported in other cancers treated with immune
Keishi Ouchi   +8 more
wiley   +1 more source

Percutaneous Aspiration (AngioVac) of a Mitral Valve Vegetation followed by a Transcatheter Mitral Valve-in-Valve Intervention

open access: yes, 2022
The AngioVac transcatheter aspiration system (Angiodynamics) is used to percutaneously extract thrombi as well as vegetations typically growing from the right heart. We report a case of a failed mitral stented bioprosthesis due to a large vegetation that
Gaurav Dhar   +9 more
core   +1 more source

The Electrophysiology Experience in Patients With Ebstein's Anomaly Undergoing the da Silva Cone Repair at UPMC Children's Hospital of Pittsburgh

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction The da Silva Cone repair (CR) has demonstrated to be an effective intervention for Ebstein's anomaly (EA). Perioperative management can be complicated by arrhythmias, but previous studies showed improvement with preoperative catheter and intraoperative surgical ablation.
Brock A. Karolcik   +6 more
wiley   +1 more source

Left Bundle Branch Area Pacing versus Deep Septal Pacing in Patients After Transcatheter Aortic Valve Replacement

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Left bundle branch area pacing (LBBAP) has been reported to improve long‐term clinical outcomes in patients requiring permanent pacemaker implantation (PPMI) after transcatheter aortic valve replacement (TAVR). Deep septal pacing (DSP) has emerged as a potential alternative to LBBAP.
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Transcatheter Intervention for Heart Failure: Excitement, Progress, and Trepidation. [PDF]

open access: yesJ Soc Cardiovasc Angiogr Interv, 2023
Généreux P, Testani JM.
europepmc   +1 more source

The Future of Transcatheter Interventions

open access: yesJACC: Case Reports, 2020
Patterson, Tiffany   +4 more
openaire   +4 more sources

Zero‐Contrast Versus Contrast‐Guided Left Atrial Appendage Occlusion: A Comparative Analysis of Procedural and Long‐Term Outcomes

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Zero‐contrast left atrial appendage occlusion yielded high procedural success and similar periprocedural adverse event rates compared to the contrast‐guided approach. At 45‐day follow‐up, successful LAA closure (defined as peri‐device leak ≤ 5 mm) and device‐related thrombus rates were similar.
Joe Demian   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy